Cart
sales@molnova.com
R-7050
CAS No. 303997-35-5
R-7050 ( R-7050; R 7050; R7050; TNF-α Antagonist III )
Catalog No. M18394 CAS No. 303997-35-5
R-7050 is a tumor necrosis factor receptor (TNFR) antagonist with greater selectivity toward TNFα.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 34 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 195 | In Stock |
|
| 50MG | 267 | In Stock |
|
| 100MG | 439 | In Stock |
|
| 500MG | 954 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameR-7050
-
NoteResearch use only, not for human use.
-
Brief DescriptionR-7050 is a tumor necrosis factor receptor (TNFR) antagonist with greater selectivity toward TNFα.
-
DescriptionR-7050 is a TNF-α receptor antagonist. It acts by blocking receptor-adaptor molecule complex formation and subsequent receptor internalization, but not TNF-α ligand-receptor binding.
-
SynonymsR-7050; R 7050; R7050; TNF-α Antagonist III
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNF-α
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number303997-35-5
-
Formula Weight380.77
-
Molecular FormulaC16H8ClF3N4S
-
Purity98%
-
SolubilityDMSO : 25 mg/mL 65.66 mM;
-
SMILESFC(F)(F)c3nnc2c(nc1ccc(Cl)cc1n23)Sc4ccccc4
-
Chemical Name8-Chloro-4-(phenylthio)-1-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gururaja TL, et al. A class of small molecules that inhibit TNFalpha-induced survival and death pathways viaprevention of interactions between TNFalphaRI, TRADD, and RIP1. Chem Biol. 2007 Oct;14(10):1105-18.
molnova catalog
related products
-
Moringin
Moringin is an isothiocyanate obtained from myrosinase-mediated hydrolysis of the glucosinolate precursor glucoMoringin present in Moringa oleifera seeds. Moringin has anti-inflammatory and antioxidative properties.
-
Elagolix sodium
Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).
-
Desoxo-narchinol A
Desoxo-narchinol A exhibits protective effects against LPS-induced endotoxin shock and inflammation through p38 deactivation, it shows inhibitory activity against LPS-induced NO production. Desoxo-narchinol A shows cytotoxic activity against P-388 cells.
